Medsource 
Dealstreet

ELP acts on Medsource fund raise from private equity firm Xponentia Capital Partners

Pursuant to the fundraise Xponentia holds a minority stake in Medsource.

Bar & Bench

Leading In-Vitro Diagnostics (IVD) manufacturer Medsource Ozone Biomedicals Private Limited has raised an undisclosed amount from private equity firm Xponentia Capital Partners (Xponentia).

Economic Laws Practice advised Xponentia. The team included Partner Abhishek Sanyal and Senior Associate Jishnu Dhar and Associate Daryl Menezes.

Pursuant to this fundraise Xponentia holds a minority stake in Medsource.

Medsource is one of India’s largest manufacturers of IVD products supplying specialized products to labs pan-India as well exporting to over 35+ countries.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Supreme Court warns against spitting pan masala, gutka in its premises

Trilegal advises Carlyle on ₹2,100 crore stake acquisition in Edelweiss’s Nido Home Finance

SAM advises Power Finance Corp on sanctioning ₹2,046 crore for Acme Urja One’s 380 MW hybrid power project

Rewriting the rules: The 2025 Insurance Laws Amendment and its impact on India’s insurance sector

PSU employee's tweets alleging corruption by employer is misconduct under service rules: Delhi High Court

SCROLL FOR NEXT